Association of cholesterol levels and occurrence of angiographically detectable endothelial disruption during coronary angioplasty

Background: Disruption of the atherosclerotic plaque is a common feature of both acute coronary syndromes and balloon dilatation of coronary artery stenoses.

[1]  M Schartl,et al.  Use of Intravascular Ultrasound to Compare Effects of Different Strategies of Lipid-Lowering Therapy on Plaque Volume and Composition in Patients With Coronary Artery Disease , 2001, Circulation.

[2]  R. Lee.  Plaque stabilization: the role of lipid lowering. , 2000, International journal of cardiology.

[3]  Unstable angina pectoris. , 2000, The New England journal of medicine.

[4]  H. Kawano,et al.  Atherosclerotic plaques composed of a large core of foam cells covered with thin fibrous caps in twice-injured carotid arterial specimens obtained from high cholesterol diet-fed rabbits. , 2000, Journal of atherosclerosis and thrombosis.

[5]  A. Gotto,et al.  The evolving role of statins in the management of atherosclerosis. , 2000, Journal of the American College of Cardiology.

[6]  M J Davies,et al.  Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. , 1996, Circulation.

[7]  C. Bauters,et al.  Morphological changes after percutaneous transluminal coronary angioplasty of unstable plaques. Insights from serial angioscopic follow-up. , 1996, European heart journal.

[8]  V. Fuster,et al.  Coronary plaque disruption. , 1995, Circulation.

[9]  P Hall,et al.  Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. , 1995, Circulation.

[10]  Thomas J. Ryan,et al.  Guidelines for Percutaneous Transluminal Coronary Angioplasty A Report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty) , 1993, Circulation.

[11]  J. Albers,et al.  Lipid Lowering and Plaque Regression New Insights Into Prevention of Plaque Disruption and Clinical Events in Coronary Disease , 1993, Circulation.

[12]  C. Buller,et al.  Mechanisms of balloon angioplasty and directional coronary atherectomy as assessed by intracoronary ultrasound. , 1992, Journal of the American College of Cardiology.

[13]  M. Mooney,et al.  Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. , 1991, The American journal of cardiology.

[14]  T. Ryan.  Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). , 1988, Journal of the American College of Cardiology.

[15]  M. Nobuyoshi,et al.  Arterial changes after percutaneous transluminal coronary angioplasty: results at autopsy. , 1987, Journal of the American College of Cardiology.

[16]  M. Bourassa,et al.  Restenosis after successful percutaneous transluminal coronary angioplasty: the Montreal Heart Institute experience. , 1987, The American journal of cardiology.

[17]  L. Hillis,et al.  Percutaneous transluminal coronary angioplasty. , 1994, The American journal of the medical sciences.

[18]  S. Kelsey,et al.  Percutaneous Transluminal Coronary Angioplasty: Report of Complications from the National Heart, Lung, and Blood Institute PTCA Registry , 1983, Circulation.